By Staff
Friday, December 1, 2023 2:41 PM
Fonda—the company specializing in hi-tech optical solutions to help people retain their vision, even in the event of serious ophthalmic conditions, and which participates this year for the first time in Mido 2024—has completed its evolution into a Benefit Corporation.
By Staff
Friday, December 1, 2023 2:31 PM
Headwinds are going to eventually force the consumer to buckle, and I think that we’re going to see consumers have to pull back on spending for a quarter or two.
By Staff
Friday, December 1, 2023 1:54 PM
Cell phone sales are in a post-pandemic slump according to a new report from
Traqline. Consumers are less willing to buy new devices despite sales and slowing inflation. In September the top cell service providers were Verizon at 18 percent of the market, T-Mobile at 15 percent and AT&T/Cingular at 16 percent.
Meanwhile, 83 percent of consumers are more likely to purchase their cell phones from one store, with 78 percent choosing one brand of cell phone. Apple has the highest purchase rate at 87 percent.
The majority of cell phone purchases are homeowners, with 52 percent reporting being married. However, 40 percent of cell phone purchases were made by males only, while 21 percent of purchases are made with males and females involved in the purchase.
By Staff
Friday, December 1, 2023 1:27 PM
Bakers, it's just about time to get started on some practice bakes for the
holiday season. Head over to
The New York Times for seven fun, tasty and special holiday cookie recipes that you can try out now.
By Staff
Friday, December 1, 2023 8:20 AM
Did you follow the optical news this week? Take VM’s News Quiz to see how much you know. This week's quiz takes a look at VM's EyeVote Readers’ Choice Awards, an eyewear roadshow and this year’s flu shot.
By Staff
Friday, December 1, 2023 8:10 AM
This fun, retro-inspired mug would make a perfect gift for yourself or your opti-friends. You can purchase it on Etsy
here. #WeShareIt
By Staff
Friday, December 1, 2023 8:02 AM
Novavax's updated vaccine has been granted emergency-use authorization by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals aged 12 and older, the company said on Tuesday.
By Staff
Friday, December 1, 2023 12:30 AM
ReFocus Eye Health expands its partner network; Registration opens for Vision Monday's 2024 Leadership Summit; ECPs’ gross revenue decreased, Jobson Tracker says; NORA appoints new executive and advisory board officers; and
VM and
20/20 Magazine announce EyeVote Readers’ Choice Awards all topped this week’s
VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.
By Staff
Friday, December 1, 2023 12:27 AM
STAMFORD, Conn.—
ReFocus Eye Health has announced its newest partnership with
Washington Eye Institute. Founded by Dr. Michael Summerfield, Washington Eye Institute's eight clinicians provide full-scope ophthalmologic care to its patients in the greater Washington D.C. area with offices in Greenbelt, Rockville, and Cumberland, Md. "This partnership with ReFocus Eye Health enhances our efficiency and effectiveness. Leveraging the resources and knowledge of ReFocus will enable us to provide the best possible eyecare to the broader D.C. community," stated Dr. Summerfield.
By Staff
Friday, December 1, 2023 12:24 AM
CHICAGO—Prevent Blindness, the nation’s leading nonprofit eye health organization, is announcing the third annual Geographic Atrophy (GA) Awareness Week as Dec. 4-10, 2023. GA is a medical term that refers to later-stage cases of dry age-related macular degeneration (AMD). Macular degeneration is an eye condition that affects the macula of the retina. More than 8 million people in the world have GA, with an estimated 1 million in the U.S., according to the
Cleveland Clinic.
By Staff
Friday, December 1, 2023 12:21 AM
NASHVILLE, Tenn.—
Harrow, a leading U.S. eyecare pharmaceutical company, announced the completion of the transfer to Harrow of the New Drug Application for Triesence (triamcinolone acetonide injectable suspension) 40 mg/mL, a synthetic corticosteroid indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions.
By Staff
Friday, December 1, 2023 12:18 AM
SALT LAKE CITY and JUJA, Kenya—
EyeCare4Kids, a non-profit organization dedicated to providing essential eyecare to underserved communities around the world, announced the opening of a comprehensive, state-of-the-art vision clinic at Kalimoni Mission Hospital in Kenya, Africa.